Nurix Therapeutics, Inc. (NRIX)
Across 23 earnings reports since Oct 14, 2020, Nurix Therapeutics, Inc. (NRIX) has a clear post-earnings pattern. It moves ±5.76% on average after reporting and finishes higher 56.5% of the time. Its largest post-earnings gain was +20.63% (Apr 13, 2023) and its largest decline was -10.24% (Apr 10, 2024). The next earnings report is predicted for 2026-07-10 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
23
Avg Abs. Movement
±5.76%
Positive %
56.5%
Negative %
43.5%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| Apr 08, 2026 | ☀ PRE | $16.57 | $17.19 | $15.60 | 2,005,200 | -4.59% | open_in_new |
| Jan 28, 2026 | ☽ POST | $19.44 | $19.57 | $17.87 | 1,043,700 | -1.57% | open_in_new |
| Oct 09, 2025 | ☽ POST | $10.03 | $10.88 | $10.86 | 1,147,800 | -10.13% | open_in_new |
| Jul 09, 2025 | ☽ POST | $12.44 | $13.39 | $13.18 | 980,200 | -3.87% | open_in_new |
| Apr 08, 2025 | ☽ POST | $10.21 | $10.39 | $9.26 | 1,051,400 | +3.67% | open_in_new |
| Jan 28, 2025 | ☽ POST | $19.94 | $19.98 | $19.56 | 577,100 | +0.46% | open_in_new |
| Oct 11, 2024 | ☽ POST | $23.57 | $24.26 | $23.63 | 951,900 | +6.47% | open_in_new |
| Jul 11, 2024 | ☽ POST | $21.15 | $22.79 | $22.03 | 1,141,900 | +8.13% | open_in_new |
| Apr 10, 2024 | ☀ PRE | $16.67 | $17.00 | $15.69 | 3,500,500 | -10.24% | open_in_new |
| Feb 15, 2024 | ☽ POST | $9.35 | $9.94 | $9.85 | 471,200 | +0.2% | open_in_new |
| Oct 12, 2023 | ☽ POST | $6.60 | $6.72 | $6.23 | 751,100 | +2.25% | open_in_new |
| Jul 13, 2023 | ☽ POST | $10.00 | $10.35 | $10.08 | 427,500 | -3.17% | open_in_new |
| Apr 13, 2023 | ☽ POST | $9.17 | $10.23 | $10.13 | 368,300 | +20.63% | open_in_new |
| Feb 09, 2023 | ☽ POST | $11.77 | $12.03 | $11.23 | 216,300 | +3.74% | open_in_new |
| Oct 06, 2022 | ☽ POST | $12.50 | $12.56 | $11.82 | 491,300 | -7.19% | open_in_new |
| Jul 07, 2022 | ☽ POST | $14.37 | $15.67 | $15.47 | 508,800 | +14.48% | open_in_new |
| Apr 07, 2022 | ☽ POST | $13.77 | $14.30 | $13.26 | 218,100 | +11.76% | open_in_new |
| Jan 27, 2022 | ☽ POST | $18.56 | $18.77 | $17.29 | 317,000 | +2.14% | open_in_new |
| Oct 14, 2021 | ☽ POST | $29.80 | $29.89 | $28.50 | 305,900 | +1.16% | open_in_new |
| Jul 13, 2021 | ☽ POST | $23.35 | $24.21 | $23.23 | 244,800 | -2.24% | open_in_new |
| Apr 13, 2021 | ☽ POST | $26.81 | $28.25 | $26.56 | 565,500 | +12.91% | open_in_new |
| Feb 16, 2021 | ☽ POST | $38.88 | $40.13 | $39.93 | 565,800 | -0.4% | open_in_new |
| Oct 14, 2020 | ☽ POST | $25.76 | $25.79 | $24.65 | 66,600 | -1.18% | open_in_new |
Earnings Count
23
Total earnings in dataset
Avg Abs. Movement
±5.76%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260608 | open_in_new SEC.gov |
| 144 | 20260602 | open_in_new SEC.gov |
| 4 | 20260602 | open_in_new SEC.gov |
| 4 | 20260515 | open_in_new SEC.gov |
| 4 | 20260515 | open_in_new SEC.gov |
| 4 | 20260515 | open_in_new SEC.gov |
| 4 | 20260515 | open_in_new SEC.gov |
| 4 | 20260515 | open_in_new SEC.gov |
| 4 | 20260515 | open_in_new SEC.gov |
| 4 | 20260515 | open_in_new SEC.gov |
Frequently asked about NRIX earnings
When does Nurix Therapeutics, Inc. report earnings next? expand_more
Nurix Therapeutics, Inc. (NRIX)'s next earnings date is approximate for 2026-07-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does NRIX stock move after earnings? expand_more
Over 23 reports, NRIX has moved an average of ±5.76% the session after earnings, closing higher 56.5% of the time.
What was NRIX's biggest post-earnings move? expand_more
NRIX's largest post-earnings gain on record was +20.63% on Apr 13, 2023, and its largest decline was -10.24% on Apr 10, 2024.
Where can I find Nurix Therapeutics, Inc.'s SEC filings? expand_more
All of Nurix Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right